Govt Agency To Distribute Remdesivir To All Hospitals

Jaipur : The state government has issued an order that Remdesivir and other drugs will be distributed to private and government hospitals through state-run Rajasthan Medical Services Corporation Limited (RMSCL) in order to curb blackmarketing and hoarding of injections and medicines.

Through this order, the government scraps the role of private distributors in the distribution of medicines. “All private hospitals and government hospitals will receive allocated drugs only through government-run RMSCL,” said an official.

“Earlier, the private distributors were supplying to the private hospitals. Now, the private distributors will surrender all the drugs they receive to the government. The distribution of Remdesivir injections and other drugs will be distributed to private hospitals and government hospitals only after the approval from the district-level committees formed by the collectors.

Jaipur police on Friday held three persons for black-marketing of Remdesivir injections in Dudu. According to police, they were trying to sell two injections at Rs 60,000.

The state on Friday received 1500 vials of Remdesivir injections from Dr Redyy’s and 3000 vials from Zydus Cadilla. The state requires 15,000 vials of Remdesivir injections per day.

The central government has scaled up the allocation of the drugs for Rajasthan to 1,41,600 vials up toMay 9. Among all the seven companies, Zydus Cadila will supply 43,000 vials, Mylan will supply 32,000vials, Cipla will supply 26,500 vials and Hetero will supply 24,000 vials of Remdesivir.

Apart from these, Syngene/Sun will supply 1,600 vials of Remdesivir, Jubilant will supply 8,000 vials and Dr Redyy’s will supply 6,500 vials.

  • Related Posts

    • Pharma
    • August 1, 2025
    • 45 views
    Trump pressures 17 pharma CEOs to cut US drug prices

    WASHINGTON, July 31 (Reuters) – President Donald Trump sent letters to the leaders of 17 major pharmaceutical companies outlining how they should slash U.S. prescription drug prices to match those paid overseas,…

    • Pharma
    • August 1, 2025
    • 49 views
    Nifty settles below 24,600 level; broader mkt underperforms; pharma shares tumble

    The headline equity benchmarks ended with significant losses today, as investors turned cautious following the U.S. imposition of steep tariffs on multiple trade partners and the reaffirmation of a 25%…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Trump pressures 17 pharma CEOs to cut US drug prices

    Trump pressures 17 pharma CEOs to cut US drug prices

    Nifty settles below 24,600 level; broader mkt underperforms; pharma shares tumble

    Nifty settles below 24,600 level; broader mkt underperforms; pharma shares tumble

    Karnataka issues order to merge Ayush drug dept with State FDA

    Karnataka issues order to merge Ayush drug dept with State FDA

    Orchid Pharma buyback rights to novel antibiotic; stock up 5%

    Orchid Pharma buyback rights to novel antibiotic; stock up 5%